Feedback
Adrenoleukodystrophy, X- Linked (ABCD1) Sequencing
2011902
Ordering Recommendation

Useful to confirm diagnosis or carrier status for X-linked adrenoleukodystrophy. Detects most pathogenic variants.

Mnemonic
ABCD1 FGS
Methodology
Polymerase Chain Reaction/Sequencing
Performed
Sun-Sat
Reported
14-21 days
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Lavender (EDTA), pink (K2EDTA), or yellow (ACD Solution A or B). 
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL) 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
 
Remarks
 
Stability
Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable 
Reference Interval
Interpretive Data
Refer to Report

Compliance Statement C: The performance characteristics of this test were validated by ARUP Laboratories. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test. However, FDA approval or clearance is currently not required for clinical use of this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. ARUP is authorized under Clinical Laboratory Improvement Amendments (CLIA) and by all states to perform high-complexity testing. Counseling and informed consent are recommended for genetic testing. Consent forms are available online.

Note
CPT Code(s)
81405
Components
Component Test Code*Component Chart NameLOINC
2011903ABCD1 Sequencing Specimen31208-2
2011904ABCD1 Sequencing Interpretation53836-3
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • ABCD1
  • Adrenomyeloneuropathy
  • ALD
  • AMN
  • X-ALD
  • X-Linked adrenoleukodystrophy